Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development

Experimental Hematology

Volumn 28, Issue 7, 2000, Pages 833-840

  Yamane, Toshiyuki ^a   Kunisada, Takahiro ^a   Yamazaki, Hidetoshi ^a   Nakano, Toru ^b   Orkin, Stuart H ^c   Hayashi, Shin Ichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Embryonic stem cells; GATA 2,; Macrophage colony stimulating factor; Osteoclast; Osteoclast differentiation factor osteoprotegerin ligand; SCL tal 1

Indexed keywords

COLONY STIMULATING FACTOR 1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL MUTANT; CELL STRUCTURE; COLONY FORMING UNIT M; CONTROLLED STUDY; EMBRYO CELL; GENE DELETION; HEMATOPOIETIC STEM CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; COLONY-FORMING UNITS ASSAY; DNA-BINDING PROTEINS; ERYTHROID-SPECIFIC DNA-BINDING FACTORS; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; HELIX-LOOP-HELIX MOTIFS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 0034126954     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00175-2     Document Type: Article

References (51)

1. Suda T., Udagawa N., Takahashi N. Cells of bone. osteoclast generation Bilezikian J.P., Raisz L.G., Roden G.A. Principles of bone biology. 1996;Academic Press Inc, New York. 87p.
2. Suda T., Takahashi N., Martin T.J. Modulation of osteoclast differentiation. Endocr Rev. 13:1992;66.
3. Roodman G.D. Advances in bone biology. the osteoclast Endocr Rev. 17:1996;308.
4. Hayashi S.I., Yamane T., Miyamoto A.et al. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol. 76:1998;911.
5. Yoshida H., Hayashi S.I., Kunisada T.et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 345:1990;442.
6. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W. Jr. et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 87:1990;4828.
7. Wang Z.Q., Ovitt C., Grigoriadis A.E.et al. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741.
8. Johnson R.S., Spiegelman B.M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577.
9. Grigoriadis A.E., Wang Z.Q., Cecchini M.G.et al. c-Fos. a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science. 266:1994;443.
10. Tondravi M.M., McKercher S.R., Anderson K.et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 386:1997;81.
11. Franzoso G., Carlson L., Xig L.et al. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:1997;3482.
12. Iotsova V., Caamano J., Loy J.et al. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat Med. 3:1997;1285.
13. Kong Y.Y., Yoshida H., Sarosi I.et al. OPGL is akey regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:1999;315.
14. Dougall W.C., Glaccum M., Charrier K.et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:1999;2412.
15. Takahashi N., Udagawa N., Tanaka S.et al. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. Dev Biol. 163:1994;212.
16. Udagawa N., Takahashi N., Akatsu T.et al. Origin of osteoclasts. mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells Proc Natl Acad Sci U S A. 87:1990;7260.
17. Miyamoto A., Kunisada T., Hemmi H.et al. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. Biochem Biophys Res Commun. 24:1998;703.
18. Hayashi S.I., Miyamoto A., Yamane T.et al. Osteoclast precursors in bone marrow and peritoneal cavity. J Cell Physiol. 170:1997;241.
19. Sudo T., Nishikawa S., Ogawa M.et al. Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene. 11:1995;2469.
20. Ogawa M., Matsuzaki Y., Nishikawa S.et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 174:1991;63.
21. Hattersley G., Kerby J.A., Chambers T.J. Identification of osteoclast precursors in multilineage hemopoietic colonies. Endocrinology. 128:1991;259.
22. Hayase Y., Muguruma Y., Lee M.Y. Osteoclast development from hematopoietic stem cells. apparent divergence of the osteoclast lineage prior to macrophage commitment Exp Hematol. 25:1997;19.
23. Yamane T., Kunisada T., Yamazaki H.et al. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood. 90:1997;3516.
24. Nakano T., Kodama H., Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 265:1994;1098.
25. Orkin S.H. GATA-binding transcription factors in hematopoietic cells. Blood. 80:1992;575.
26. Weiss M.J., Orkin S.H. GATA transcription factors. key regulators of hematopoiesis Exp Hematol. 23:1995;99.
27. Pevny L., Simon M.C., Robertson E.et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:1991;257.
28. Fujiwara Y., Browne C.P., Cunniff K.et al. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A. 93:1996;12355.
29. Weiss M.J., Keller G., Orkin S.H. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev. 8:1994;1184.
30. Pevny L., Lin C.-S., D'Agati V.et al. Development of hematopoietic cells lacking transcription factor GATA-1. Development. 121:1995;163.
31. Shivdasani R.A., Fujiwara Y., McDevitt M.A.et al. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:1997;3965.
32. Tsang A.P., Visvader J.E., Turner C.A.et al. FOG, a multitype zinc finger protein, act as a cofactor for transcription factor GATA-1 in erythroid and megakaryocyte differentiation. Cell. 90:1997;109.
33. Tsang A.P., Fujiwara Y., Hom D.B.et al. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev. 12:1998;1176.
34. Tsai F.-Y., Keller G., Kuo F.C.et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 371:1994;221.
35. Tsai F.-Y., Orkin S.H. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 89:1997;3636.
36. Begley C.G., Aplan P.D., Davey M.P.et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A. 86:1989;2031.
37. Finger L.R., Kagan J., Christopher G.et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A. 86:1989;5039.
38. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature. 373:1995;432.
39. Robb L., Lyons I., Li R.et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A. 92:1995;7075.
40. Porcher C., Swat W., Rockwell K.et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47.
41. Robb L., Elwood N.J., Elefanty A.G.et al. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15:1996;4123.
42. Yasuda H., Shima N., Nakagawa N.et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 95:1998;3597.
43. Lacey D.L., Timms E., Tan H.-L.et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93:1998;165.
44. Yasuda H., Shima N., Nakagawa N.et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG). a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology. 139:1998;1329.
45. Simonet W.S., Lacey D.L., Dunstan C.R.et al. Osteoprotegerin. a novel secreted protein involved in the regulation of bone density Cell. 89:1997;309.
46. Nishikawa S.I., Ogawa M., Nishikawa S., Kunisada T., Kodama H. B lymphopoiesis on stromal cell clone. stromal cell clones acting on different stages of B cell differentiation Eur J Immunol. 18:1988;1767.
47. Kodama H., Nose M., Niida S.et al. Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol. 22:1994;979.
48. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell. 69:1992;915.
49. Robertson E., Bradley A., Kuehn M.et al. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature. 323:1986;445.
50. Doetschman T.C., Eistetter H., Katz M.et al. The in vitro development of blastocyst-derived embryonic stem cell lines. formation of visceral yolk sac, blood islands and myocardium J Embryol Exp Morphol. 87:1985;27.
51. Udagawa N., Takahashi N., Akatsu T.et al. The bone marrow-derived stromal cell line MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1989;1805.